Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Chengdu Kanghua Biological Products Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥45.04 |
52 Week High | CN¥84.05 |
52 Week Low | CN¥44.78 |
Beta | 2.41 |
11 Month Change | -13.70% |
3 Month Change | -19.46% |
1 Year Change | -29.28% |
33 Year Change | -60.32% |
5 Year Change | n/a |
Change since IPO | 0.0099% |
Recent News & Updates
The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet
Sep 13We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt
Jun 26Recent updates
The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet
Sep 13We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt
Jun 26Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares
Feb 27Shareholder Returns
300841 | CN Biotechs | CN Market | |
---|---|---|---|
7D | -6.3% | -3.2% | -2.6% |
1Y | -29.3% | -26.0% | -20.6% |
Return vs Industry: 300841 underperformed the CN Biotechs industry which returned -26% over the past year.
Return vs Market: 300841 underperformed the CN Market which returned -20.6% over the past year.
Price Volatility
300841 volatility | |
---|---|
300841 Average Weekly Movement | 4.6% |
Biotechs Industry Average Movement | 5.8% |
Market Average Movement | 5.4% |
10% most volatile stocks in CN Market | 8.6% |
10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 300841's share price has been volatile over the past 3 months.
Volatility Over Time: 300841's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 700 | Hongbo Wu | www.kangh.com |
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines.
Chengdu Kanghua Biological Products Co., Ltd. Fundamentals Summary
300841 fundamental statistics | |
---|---|
Market cap | CN¥6.07b |
Earnings (TTM) | CN¥567.57m |
Revenue (TTM) | CN¥1.68b |
10.4x
P/E Ratio3.5x
P/S RatioIs 300841 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300841 income statement (TTM) | |
---|---|
Revenue | CN¥1.68b |
Cost of Revenue | CN¥102.51m |
Gross Profit | CN¥1.58b |
Other Expenses | CN¥1.01b |
Earnings | CN¥567.57m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.33 |
Gross Margin | 93.91% |
Net Profit Margin | 33.70% |
Debt/Equity Ratio | 5.1% |
How did 300841 perform over the long term?
See historical performance and comparison